DSIP 5mg

Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided. For research use only – not for human or veterinary use.   Product Overview DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring neuropeptide examined in research settings for its biochemical relevance to sleep regulation, stress-response modulation and neuroendocrine activity. This lyophilized 5 mg peptide supports controlled laboratory evaluation of stability, identity and biochemical signalling behaviour.   Peptide Overview Between 2010 and 2025 DSIP has been studied for its involvement in neuropeptide pathways associated with circadian processes, neuroendocrine interactions and cellular response to physiological stress markers. Its small-molecule characteristics and defined purity profile make it suitable for structured in-vitro research.   Historical Background and Scientific Context Originally isolated in the 1970s, DSIP gained renewed scientific interest between 2015 and 2025 as laboratories explored its potential influence on biochemical processes related to sleep architecture and stress adaptation. Its stability and reproducibility under controlled conditions have made it a relevant target in experimental neurobiochemistry.   Mechanistic Focus in Research

• Neuropeptide signalling and sleep-cycle modelling
• Biochemical pathways associated with circadian regulation
• In-vitro studies on neuroendocrine interactions
• Stress-response biochemical modelling
• Comparative analysis with related neuropeptide compounds

  Analytical Verification (COA) Independent Liquilabs analysis confirms full analytical validation for Batch GF082025025. Key results include:

• Assay Content: 5.07 mg
• Identification – Retention Time: 0.999
• Identification – Spectrum: 992
• Purity: 99.58 percent
• Endotoxins: below 0.001 EU per mg
• Microbial Growth: not detected for aerobic count, yeast or mold
• Heavy Metals: not detected including arsenic cadmium lead mercury nickel cobalt vanadium

All analytical data were established using validated chromatographic, spectroscopic and microbiological procedures ensuring transparency and traceability.   Research Applications

• Neuropeptide pathway evaluation
• Sleep-cycle and circadian-rhythm modelling
• Stress-response and neuroendocrine studies
• Biochemical interaction profiling
• In-vitro neurobiological modelling experiments

 

Grail Formula Quality

Every Grail Formula research peptide undergoes independent laboratory testing for purity, identity, structural integrity and microbial safety. All batches are verified for stability, low endotoxin levels and reproducibility to ensure reliable scientific outcomes.

When You Choose Grail Formula…

Researchers receive fully documented peptides with batch-number traceability, sealed-vial integrity and transparent laboratory verification. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation
• Supplied to another party for human investigational use

• Verified and analysed with Liquilabs s.r.o. Czechia
• 99.58 percent purity with validated assay content
• No detectable heavy metals or microbial contamination
• Endotoxin below 0.001 EU per mg
• Batch GF082025025 – Published October 2025
• EU shipments include bacteriostatic water
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.